Creatinine-Based vancomycin dosing regimens in Neonates: There is more to consider than the variation in drug assay

Pharmacotherapy

Volumn 32, Issue 9, 2012, Pages

  Allegaert, Karel ^a,b,c   Van Den Anker, John N ^d  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; HEMOGLOBIN F; PENICILLIN DERIVATIVE; VANCOMYCIN;

ANALYTIC METHOD; CREATININE BLOOD LEVEL; DOSAGE SCHEDULE COMPARISON; DRUG DETERMINATION; DRUG DOSE REGIMEN; ENZYME ASSAY; EXTREMELY LOW BIRTH WEIGHT; HUMAN; JAFFE TECHNIQUE; NEWBORN; NEWBORN ASSESSMENT; NOTE; PREMATURITY; TERM BIRTH;

ANTI-BACTERIAL AGENTS; DRUG MONITORING; HUMANS; INFANT, PREMATURE; MALE; MODELS, BIOLOGICAL; VANCOMYCIN;

EID: 84867621255     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.2012.01180.x     Document Type: Note

References (3)

1. Mehrotra N, Tang L, Phelps SJ, Meibohm B. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations. Pharmacotherapy 2012;32:408-419.
2. Van denAnker JN. Getting the dose of vancomycin right in the neonate. Int J Clin Pharmacol Ther2011;49:247-249.
3. Allegaert K, Kuppens M, Mekahli D, et al. Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method. J Matern Fetal Neonatal Med 2012. doi: 10.3109/14767058.2012.657277